Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Fujifilm Holdings Corp.

www.fujifilmholdings.com

Latest From Fujifilm Holdings Corp.

Stockwatch: Coronavirus And Commercialization

The prices of biotechnology and pharmaceutical sector indices continue to be comparatively robust in the face of big falls in global markets as investors expect new drugs and vaccines to be generated by the sector. While it is largely accepted that the life science sector will eventually ride to the rescue, bumper profits are far from guaranteed.

Coronavirus COVID-19 Stockwatch

Coronavirus Update: Fujifilm Drug Shows Promise, Arrowhead Halts Trial Screening, Novartis Unveils COVID-19 Measures

Flu drug produces encouraging results in Chinese trials, while Novartis CEO Vas Narasimhan shows his public health background with package of measures.

International Coronavirus COVID-19

Biosimilars: A Decade In Review

The past decade has been transformative for the global biosimilars industry as regulators, developers, physicians, patients and payers from all over the world have grappled with complex, and often market-shaping, issues.

Biosimilars Regulation

FujiFilm Strengthens Position By Adding Hitachi’s Diagnostic Imaging Unit

FujiFilm has signed an agreement to to buy Hitachi’s Diagnostic Imaging Business for $1.63bn to position itself among the top diagnostic imaging heavyweights.

M & A Deals
See All

Company Information

UsernamePublicRestriction

Register